Cialis (Eli Lilly and Company)
Welcome to the PulseAid listing for the Cialis drug offered from Eli Lilly and Company. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Tadalafil |
| SUBSTANCE NAME: | TADALAFIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-11-26 |
| END MARKETING DATE: | 0000-00-00 |
Cialis HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cialis from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2003-11-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-4462_a300bb97-176e-4771-8b31-3246d3f773f8 |
| PRODUCT NDC: | 0002-4462 |
| APPLICATION NUMBER: | NDA021368 |
Other TADALAFIL Pharmaceutical Manufacturers / Labelers:
